Bladé, Joan http://orcid.org/0000-0002-4563-3405
Beksac, Meral
Caers, Jo http://orcid.org/0000-0002-3175-1195
Jurczyszyn, Artur http://orcid.org/0000-0001-9796-8365
von Lilienfeld-Toal, Marie http://orcid.org/0000-0002-9756-3541
Moreau, Philippe
Rasche, Leo http://orcid.org/0000-0002-9536-9649
Rosiñol, Laura http://orcid.org/0000-0002-2534-9239
Usmani, Saad Z.
Zamagni, Elena
Richardson, Paul http://orcid.org/0000-0002-7426-8865
Article History
Received: 8 July 2021
Revised: 26 November 2021
Accepted: 7 March 2022
First Online: 21 March 2022
Competing interests
: J.B. has received speaker/lecture honoraria from Janssen, Celgene/BMS, Amgen, Takeda, and Oncopeptides. M.B. has received speaker honoraria from Amgen, Oncopeptides, Janssen, Sanofi, and Takeda. Jo Caers has received research funding from Takeda and Janssen; and honoraria from Janssen, Amgen, BMS-Celgene, and Sanofi. A.J. has received honoraria from Janssen, BMS, Takeda, Sanofi, GSK, Karyopharm, Oncopeptides, and Amgen. M.v.L.-T. has received research funding from Celgene and Oncopeptides; and honoraria from BMS/Celgene, Oncopeptides, Janssen, GSK, and Takeda. Philippe Moreau has received honoraria from Janssen, Celgene, Amgen, AbbVie, Oncopeptides, and Sanofi. Leo Rasche has received honoraria from BMS/Celgene, Sanofi, GSK, Oncopeptides, and Janssen. Laura Rosiñol has received speaker honoraria from Janssen, Celgene, Amgen, Takeda, GSK, and Sanofi. S.Z.U. has received research funding and/or honoraria from Amgen, Celgene, Janssen, Takeda, BMS, Oncopeptides, and Sanofi. E.Z. has received honoraria from, and been an advisory board member for, Janssen, BMS, Takeda, Sanofi, GSK, Karyopharm, Oncopeptides, and Amgen. P.R. has received institutional research support from Oncopeptides, Celgene/BMS, Takeda, and Karyopharm. He has received honoraria for his role as an Advisory Committee member from Karyopharm, Oncopeptides, Celgene/BMS, Takeda, Janssen, Sanofi, Secura Bio, GSK, Regeneron, AstraZeneca, and Protocol Intelligence.